Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.

Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS.

Diabetes Care. 2010 Jun;33(6):1337-43. doi: 10.2337/dc10-0227. Epub 2010 Mar 23.

2.

Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH.

Diabetes Care. 2014;37(1):226-34. doi: 10.2337/dc13-0985. Epub 2013 Aug 12.

3.

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS.

Clin J Am Soc Nephrol. 2008 May;3(3):706-13. doi: 10.2215/CJN.04271007. Epub 2008 Feb 13.

4.
5.

Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002.

Odden MC, Amadu AR, Smit E, Lo L, Peralta CA.

Am J Kidney Dis. 2014 Oct;64(4):550-7. doi: 10.1053/j.ajkd.2014.04.024. Epub 2014 Jun 4.

6.

Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.

Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST.

Kidney Int. 2013 Jun;83(6):1169-76. doi: 10.1038/ki.2013.7. Epub 2013 Feb 20. Erratum in: Kidney Int. 2013 Aug;84(2):419.

8.

Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.

Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F; MMKD Study Group..

Exp Gerontol. 2008 Apr;43(4):347-52. doi: 10.1016/j.exger.2008.01.006. Epub 2008 Jan 26.

PMID:
18294794
9.

Serum Uric Acid and Risk of CKD in Type 2 Diabetes.

De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Feig D, Johnson RJ, Pontremoli R; AMD-Annals Study Group..

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1921-9. doi: 10.2215/CJN.03140315. Epub 2015 Sep 4.

10.

Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.

Bjornstad P, Snell-Bergeon JK, Rewers M, Jalal D, Chonchol MB, Johnson RJ, Maahs DM.

Diabetes Care. 2013 Nov;36(11):3678-83. doi: 10.2337/dc13-0631. Epub 2013 Sep 11.

11.

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

Steinke JM, Mauer M; International Diabetic Nephropathy Study Group..

Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.

PMID:
18806710
12.

Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.

Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato S, Penno G.

Clin Chem. 2007 Mar;53(3):480-8. Epub 2007 Jan 26.

13.

Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes.

Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, Krolewski AS.

Diabetes Care. 2009 May;32(5):889-93. doi: 10.2337/dc08-1560. Epub 2009 Feb 5.

14.

The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.

Drummond K, Mauer M; International Diabetic Nephropathy Study Group..

Diabetes. 2002 May;51(5):1580-7.

15.

Cystatin C, albuminuria, and mortality among older adults with diabetes.

de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, Rifkin DE, Sarnak MJ, Shlipak MG, Siscovick DS.

Diabetes Care. 2009 Oct;32(10):1833-8. doi: 10.2337/dc09-0191. Epub 2009 Jul 8.

16.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

17.

Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population.

Satirapoj B, Supasyndh O, Chaiprasert A, Ruangkanchanasetr P, Kanjanakul I, Phulsuksombuti D, Utainam D, Choovichian P.

Nephrology (Carlton). 2010 Mar;15(2):253-8. doi: 10.1111/j.1440-1797.2009.01179.x.

PMID:
20470288
18.

Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.

Spanaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A; Mild and Moderate Kidney Disease (MMKD) Study Group..

Clin Chem. 2010 May;56(5):740-9. doi: 10.1373/clinchem.2009.138826. Epub 2010 Mar 11.

19.

Uric acid and incident kidney disease in the community.

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS.

J Am Soc Nephrol. 2008 Jun;19(6):1204-11. doi: 10.1681/ASN.2007101075. Epub 2008 Mar 12.

20.

Supplemental Content

Support Center